HealthStream (NASDAQ:HSTM - Get Free Report) will release its earnings data after the market closes on Monday, April 22nd. Analysts expect HealthStream to post earnings of $0.10 per share for the quarter.
HealthStream (NASDAQ:HSTM - Get Free Report) last released its quarterly earnings data on Monday, February 19th. The technology company reported $0.15 earnings per share for the quarter, beating analysts' consensus estimates of $0.08 by $0.07. The business had revenue of $70.58 million during the quarter, compared to analyst estimates of $71.83 million. HealthStream had a net margin of 5.45% and a return on equity of 4.71%. During the same period in the previous year, the business earned $0.08 EPS. On average, analysts expect HealthStream to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
HealthStream Price Performance
Shares of NASDAQ:HSTM traded down $0.20 during trading on Wednesday, hitting $24.47. 103,792 shares of the company were exchanged, compared to its average volume of 97,324. The company has a market cap of $743.89 million, a PE ratio of 48.94, a P/E/G ratio of 4.02 and a beta of 0.36. HealthStream has a 52-week low of $20.47 and a 52-week high of $29.12. The stock has a 50 day moving average of $26.38 and a 200 day moving average of $25.78.
HealthStream Increases Dividend
The business also recently disclosed a quarterly dividend, which was paid on Friday, March 22nd. Investors of record on Monday, March 11th were issued a dividend of $0.028 per share. This is a boost from HealthStream's previous quarterly dividend of $0.03. The ex-dividend date was Friday, March 8th. This represents a $0.11 dividend on an annualized basis and a yield of 0.46%. HealthStream's dividend payout ratio is 22.00%.
Analyst Upgrades and Downgrades
Several equities research analysts have recently weighed in on the company. StockNews.com upgraded HealthStream from a "buy" rating to a "strong-buy" rating in a research report on Thursday, April 11th. Barclays assumed coverage on shares of HealthStream in a research note on Wednesday, January 3rd. They issued an "overweight" rating and a $32.00 target price on the stock. Finally, William Blair restated an "outperform" rating on shares of HealthStream in a research report on Tuesday, February 20th. One investment analyst has rated the stock with a hold rating, two have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Buy" and a consensus price target of $32.00.
Get Our Latest Research Report on HSTM
Insider Transactions at HealthStream
In related news, EVP Michael Sousa sold 15,000 shares of the firm's stock in a transaction that occurred on Monday, February 26th. The shares were sold at an average price of $27.25, for a total value of $408,750.00. Following the sale, the executive vice president now directly owns 42,525 shares of the company's stock, valued at $1,158,806.25. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, EVP Michael Sousa sold 15,000 shares of the business's stock in a transaction that occurred on Monday, February 26th. The stock was sold at an average price of $27.25, for a total value of $408,750.00. Following the completion of the sale, the executive vice president now owns 42,525 shares in the company, valued at approximately $1,158,806.25. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Trisha L. Coady sold 7,000 shares of the business's stock in a transaction that occurred on Thursday, February 22nd. The stock was sold at an average price of $26.34, for a total transaction of $184,380.00. Following the completion of the sale, the senior vice president now owns 14,693 shares of the company's stock, valued at $387,013.62. The disclosure for this sale can be found here. 21.30% of the stock is owned by insiders.
Institutional Investors Weigh In On HealthStream
A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Vanguard Group Inc. increased its stake in HealthStream by 0.5% in the 1st quarter. Vanguard Group Inc. now owns 2,751,207 shares of the technology company's stock worth $54,804,000 after purchasing an additional 13,515 shares during the period. Dimensional Fund Advisors LP increased its stake in shares of HealthStream by 0.8% in the first quarter. Dimensional Fund Advisors LP now owns 1,531,106 shares of the technology company's stock worth $41,491,000 after buying an additional 12,475 shares during the period. State Street Corp increased its stake in shares of HealthStream by 0.3% in the first quarter. State Street Corp now owns 926,306 shares of the technology company's stock worth $25,103,000 after buying an additional 2,722 shares during the period. Punch & Associates Investment Management Inc. raised its holdings in HealthStream by 9.3% during the 1st quarter. Punch & Associates Investment Management Inc. now owns 781,333 shares of the technology company's stock valued at $21,174,000 after buying an additional 66,361 shares during the last quarter. Finally, Renaissance Technologies LLC boosted its position in HealthStream by 6.4% during the 2nd quarter. Renaissance Technologies LLC now owns 622,000 shares of the technology company's stock valued at $15,276,000 after buying an additional 37,300 shares during the period. Institutional investors own 69.58% of the company's stock.
About HealthStream
(
Get Free Report)
HealthStream, Inc provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company's solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider HealthStream, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthStream wasn't on the list.
While HealthStream currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
